Allrockbio
1 known investors
AllRock Bio develops novel drug therapies targeting pulmonary hypertension and fibrotic lung diseases, with a lead program focused on ROCK inhibitors for pulmonary arterial hypertension and related conditions. The company is dedicated to accelerating clinical development and bringing life-saving treatments to patients worldwide.
BiotechDigital HealthMedical Devices